全文获取类型
收费全文 | 23372篇 |
免费 | 2039篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 218篇 |
儿科学 | 850篇 |
妇产科学 | 650篇 |
基础医学 | 3492篇 |
口腔科学 | 496篇 |
临床医学 | 2222篇 |
内科学 | 4983篇 |
皮肤病学 | 594篇 |
神经病学 | 2247篇 |
特种医学 | 648篇 |
外国民族医学 | 1篇 |
外科学 | 2748篇 |
综合类 | 268篇 |
一般理论 | 29篇 |
预防医学 | 2318篇 |
眼科学 | 586篇 |
药学 | 1346篇 |
中国医学 | 8篇 |
肿瘤学 | 1748篇 |
出版年
2023年 | 210篇 |
2021年 | 641篇 |
2020年 | 393篇 |
2019年 | 536篇 |
2018年 | 562篇 |
2017年 | 392篇 |
2016年 | 438篇 |
2015年 | 471篇 |
2014年 | 606篇 |
2013年 | 814篇 |
2012年 | 1191篇 |
2011年 | 1126篇 |
2010年 | 588篇 |
2009年 | 545篇 |
2008年 | 974篇 |
2007年 | 1024篇 |
2006年 | 946篇 |
2005年 | 953篇 |
2004年 | 831篇 |
2003年 | 790篇 |
2002年 | 771篇 |
2001年 | 661篇 |
2000年 | 732篇 |
1999年 | 586篇 |
1998年 | 209篇 |
1997年 | 179篇 |
1995年 | 197篇 |
1994年 | 171篇 |
1993年 | 169篇 |
1992年 | 507篇 |
1991年 | 517篇 |
1990年 | 451篇 |
1989年 | 456篇 |
1988年 | 428篇 |
1987年 | 448篇 |
1986年 | 413篇 |
1985年 | 401篇 |
1984年 | 360篇 |
1983年 | 247篇 |
1981年 | 163篇 |
1980年 | 198篇 |
1979年 | 265篇 |
1978年 | 216篇 |
1977年 | 174篇 |
1976年 | 186篇 |
1975年 | 175篇 |
1974年 | 222篇 |
1973年 | 207篇 |
1972年 | 176篇 |
1971年 | 170篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
The use of radiation for primary liver cancers has historically been limited because of the risk of radiation-induced liver disease. Treatment fields have become more conformal because of several technical advances, and this has allowed for dose escalation. Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is now able to safely treat liver tumors to ablative doses while sparing functional liver parenchyma by using highly conformal therapy. Several retrospective and small prospective studies have examined the use of SBRT for liver cancers; however, there is a lack of well-powered randomized studies to definitively guide management in these settings. Recent advances in systemic therapy for primary liver cancers have improved outcomes; however, the optimal selection criteria for SBRT as a local therapy remain unclear among other liver-directed options such as radiofrequency ablation, transarterial chemoembolization, and radioembolization. 相似文献
4.
Journal of Neuro-Oncology - Craniopharyngiomas are locally-aggressive tumors arising along the hypothalamic-pituitary axis. Treatment is nuanced as a result of their proximity and adherence to... 相似文献
5.
6.
Tiffany Li Hannah C. Timmins Tracy King Matthew C. Kiernan David Goldstein Susanna B. Park 《Hematological oncology》2020,38(3):229-243
Bortezomib-induced peripheral neuropathy (BIPN) is a common toxicity associated with the treatment of multiple myeloma (MM), typically requiring dose reduction, delay, or cessation of treatment protocol. This systematic review aimed to investigate risk factors, trends, and variability associated with the development of BIPN. Searches were undertaken using Medline, PubMed, Cochrane Central Register of Controlled Trials, Embase, Scopus, and Web of Science. Additional studies were identified by investigating authors' bibliographic references cited by original and review articles. Articles that reported on neuropathy in phase III randomised control trials involving bortezomib in any treatment arm for the treatment of MM were included in this review. A total of 43 full text articles met criteria, which examined 23 phase III trials (N = 8218). Overall incidence of neuropathy ranged from 8.4% to 80.5% (median = 37.8%) and severe neuropathy (grade 3-4) ranged from 1% to 33.2% (median = 8%). Similar reports of neuropathy of any grade and severe neuropathy were observed between the newly diagnosed and relapsed cohort. Bortezomib regimens with reduced dose intensity were associated with reduced neuropathy incidence. Increased cumulative dosing levels, intravenous compared with subcutaneous administration and combination therapy with thalidomide were associated with higher rates of BIPN. This analysis revealed that BIPN is a significant toxicity. More sensitive measures are required to capture the incidence and severity of BIPN. Better understanding of risk factors and reversibility profiles will minimise the number of cancer survivors living with residual treatment side effects. 相似文献
7.
Anastasia Kariagina Elena Morozova Reyhane Hoshyar Mark D. Aupperlee Mitchell A. Borin Sandra Z. Haslam Richard C. Schwartz 《Oncotarget》2020,11(48):4465
Benzophenone-3 is a putative endocrine disrupting chemical and common ingredient in sunscreens. The potential of endocrine disrupting chemicals to act as agonists or antagonists in critical hormonally regulated processes, such as mammary gland development and mammary tumorigenesis, demands evaluation of its potential in promoting breast cancer. This study identifies the effects of BP-3 on mammary tumorigenesis with high-fat diet during puberty versus adulthood in Trp53-null transplant BALB/c mice. Benzophenone-3 exposure yielded levels in urine similar to humans subjected to heavy topical sunscreen exposure. Benzophenone-3 was protective for epithelial tumorigenesis in mice fed lifelong low-fat diet, while promotional for epithelial tumorigenesis in mice fed adult high-fat diet. Benzophenone-3 increased tumor cell proliferation, decreased tumor cell apoptosis, and increased tumor vascularity dependent on specific dietary regimen and tumor histopathology. Even in instances of an ostensibly protective effect, other parameters suggest greater risk. Although benzophenone-3 seemed protective on low-fat diet, spindle cell tumors arising in these mice showed increased proliferation and decreased apoptosis. This points to a need for further studies of benzophenone-3 in both animal models and humans as a potential breast cancer risk factor, as well as a more general need to evaluate endocrine disrupting chemicals in varying dietary contexts. 相似文献
8.
Hannah S. Bell Funmi Odumosu Anna C. Martinez-Hume Heather A. Howard 《Medical anthropology》2019,38(3):224-238
Racial/ethnic identity is contingent and arbitrary, yet it is commonly used to evaluate disease risk and treatment response. Drawing on open-ended interviews with patients and clinicians in two US clinics, we explore how racialized risk is conceptualized and how it impacts patient care and experience. We found that racial/ethnic risk was a common but poorly defined construct for both patients and clinicians, who intermingled concepts of genetics, biology, behavior, and culture, while disregarding historical or structural context. We argue that racializing risk embodies social power in marked and unmarked bodies, reinforcing inequality along racial lines and undermining equitable health care. 相似文献
9.
Maarten Kruijver Jo-Anne Bright Hannah Kelly 《The Australian journal of forensic sciences》2019,51(4):S14-S17
ABSTRACTIf an unambiguous single-source DNA profile is obtained from a crime scene, then a potential person of interest can either match or not match the crime scene profile and the likelihood ratio for the single matching genotype can be easily computed. Mixed DNA profiles on the other hand are typically ambiguous and a vast number of different likelihood ratios can be obtained depending on the genotype of a potential person of interest that is compared with the mixture later. In the absence of a person of interest it can be unclear how suitable the profile is for discriminating between donors and non-donors. We introduce a simulation method to explore the range of likelihood ratios that is expected to be obtained when a non-donor or a true donor is compared with the mixed DNA profile. Sampling is conditional on the mixture deconvolution obtained using probabilistic genotyping. These simulations help to decide whether or not a (mixed) profile is suitable for comparison to a person of interest. Moreover, the methods can be used to determine whether a profile is suitable for upload to a database and whether or not potential rework could be advised. 相似文献
10.
Linzi Wilson-Wilde Hannah Romano Stephen Smith 《The Australian journal of forensic sciences》2019,51(4):S268-S271
ABSTRACTRecent criticism of forensic science has focused on the fundamental aspects of the science, including the lack of supporting empirical studies, validation, accreditation, limitations and error rates. Proficiency tests are an essential component of accreditation and can be used to evaluate laboratory performance and identify systematic issues within components of the service provision. In 2016 we reported on the results of an analysis of 3176 CTS proficiency tests undertaken between 2005 and 2015 by Australian government service providers. The data analysed represented 43 unique CTS test types and covered 21 disciplines. Here we present further data from 2016 to 2017 and compare these results with those obtained from the previous study. These combined results further demonstrate that errors exist even though practitioners know they are examining proficiency tests and the tests undergo a review process. This study illustrates the need to continue to monitor trends in proficiency test results and also further highlights the need for well-designed, relevant, blind error rate studies to determine the approximate error rates for casework. 相似文献